This presentation is intended for professionals involved in biopharmaceutical manufacturing, facility design, and strategic operations. It will be particularly relevant to:
Process development scientists and manufacturing engineers exploring flexible facility models to support diverse therapeutic modalities.
Regulatory affairs and quality assurance specialists assessing compliance implications of multi-modal environments.
Facility planners and operations leaders evaluating single-use technologies and adaptive layouts.
CDMO executives and biopharma strategists seeking scalable, cost-effective solutions for pipeline variability.
Corporate decision-makers responsible for capital investment, sustainability, and innovation in manufacturing infrastructure.
Attendees will benefit from practical frameworks, case studies, and strategic insights to guide decision-making around multi-modal manufacturing adoption.
